Application of diffusion weighted imaging in diagnosis and therapeutic response evaluation of gastric cancer

doi:10.3877/cma.j.issn.1674-0785.2019.05.015

Abstract

Abstract:

Gastric cancer is one of the most common malignant tumors in the world. Surgical resection is currently considered to be the main treatment method, supplemented by radiotherapy and chemotherapy. Diffusion-weighted magnetic resonance imaging (MRI) can detect the diffusion of water molecules in living tissues, and then provide quantitative information by measuring the apparent diffusion coefficient (ADC). Intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) can not only observe the diffusion of tissue water molecules but also reflect the blood perfusion information of tissue microcirculation. Thus, those techniques can be used to diagnose and evaluate treatment response of gastric cancer. In this article, we review the application of DWI in the diagnosis, staging, pathological correlation and therapeutic response evaluation of gastric cancer.

Key words: Gastric cancer, Magnetic resonance diffusion-weighted imaging, Apparent diffusion coefficient, I ntravoxel incoherent motion imaging

Jing Zheng, Cui Yang, Yi Zhou, Ran Wang, Lin Yang. Application of diffusion weighted imaging in diagnosis and therapeutic response evaluation of gastric cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(05): 393-397.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2019.05.015

https://zhlcyszz.cma-cmc.com.cn/EN/Y2019/V13/I05/393

References 58

1	Washington K. 7th edition of the AJCC cancer staging manual: stomach [J]. Ann Surg Oncol, 2010, 17(12): 3077-3079.
2	Thoeny HC, De Keyzer F, Chen F, et al. Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats [J]. Radiology, 2005, 234(3): 756-764.
3	Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders [J]. Radiology, 1986, 161(2): 401-407.
4	Iima M, Le Bihan D. Clinical intravoxel incoherent motion and diffusion MR imaging: past, present, and future [J]. Radiology, 2016, 278(1): 13-32.
5	Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging [J]. Radiology, 1988, 168(2): 497-505.
6	Qayyum A. Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications [J]. Radiographics, 2009, 29(6): 1797-1810.
7	Bonekamp S, Corona-Villalobos CP, Kamel IR. Oncologic applications of diffusion-weighted MRI in the body [J]. J Magn Reson Imaging, 2012, 35(2): 257-279.
8	Joo I, Lee JM, Kim JH, et al. Prospective comparison of 3T MRI with diffusion-weighted imaging and MDCT for the preoperative TNM staging of gastric cancer [J]. J Magn Reson Imaging, 2015, 41(3): 814-821.
9	Kwee TC, Takahara T, Ochiai R, et al. Whole-body diffusion-weighted magnetic resonance imaging [J]. Eur J Radiol, 2009, 70(3): 409-417.
10	Dijkstra H, Baron P, Kappert P, et al. Effects of microperfusion in hepatic diffusion weighted imaging [J]. Eur Radiol, 2012, 22(4): 891-899.
11	唐磊，张晓鹏，孙应实, 等. 胃癌磁共振扩散加权成像:并行采集联合分次屏气多信号平均技术的临床研究 [J]. 中国医学影像技术, 2005, 21(12): 1830-1834.
12	Caivano R, Rabasco P, Lotumolo A, et al. Gastric cancer: the role of diffusion weighted imaging in the preoperative staging [J]. Cancer Invest, 2014, 32(5): 184-190.
13	朱凯，郭玉林，王卉, 等. 3.0 T MR胃癌扩散加权成像——单序列分次屏气与分序列单次屏气比较研究 [J]. 临床放射学杂志, 2011, 30(12): 1816-1819.
14	Shinya S, Sasaki T, Nakagawa Y, et al. The usefulness of diffusion-weighted imaging (DWI) for the detection of gastric cancer [J]. Hepatogastroenterology, 2007, 54(77): 1378-1381.
15	张道全，周峰. 螺旋CT与MRI对原发性胃癌病灶的诊断价值比较 [J]. 医学综述, 2015, 21(10): 1869-1871.
16	王卉，朱凯，郭玉林. 胃癌的3.0T磁共振扩散加权成像与T2加权成像比较 [J]. 宁夏医科大学学报, 2016, 38(11): 1250-1252.
17	Avcu S, Arslan H, Unal O, et al. The role of diffusion-weighted MR imaging and ADC values in the diagnosis of gastric tumors [J]. JBR-BTR, 2012, 95(1): 1-5.
18	Avcu S, Koseoglu MN, Ceylan K, et al. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions [J]. Br J Radiol, 2011, 84(1006): 875-882.
19	黄永波，张妍，王峻. 磁共振扩散加权成像在胃癌筛查与诊断中的应用价值 [J]. 中国药物与临床, 2016, 16(12): 1756-1758.
20	De Vita F, Giuliani F, Galizia G, et al. Neo-adjuvant and adjuvant chemotherapy of gastric cancer [J]. Ann Oncol, 2007, 18 (Suppl 6): vi120-123.
21	郭燕鑫，徐张英. 胃超声造影与超声内镜对胃癌术前分期诊断对比研究 [J]. 医学影像学杂志, 2017, 27(9): 1832-1835.
22	王亮，黄品同，黄福光, 等. 超声双重造影与超声内镜对胃癌术前T分期的比较研究 [J]. 中华超声影像学杂志, 2011, 20(11): 957-961.
23	郭华，高剑波，杨学华, 等. 螺旋CT三期增强扫描对进展期胃癌的诊断价值 [J]. 实用放射学杂志, 2006, 22(9): 1059-1062.
24	康秀梅，高剑波，岳松伟, 等. 64排VCT扫描结合多种后处理技术在胃癌的诊断价值 [J]. 实用放射学杂志, 2010(3): 358-361, 367.
25	Sugita R, Ito K, Fujita N, et al. Diffusion-weighted MRI in abdominal oncology: clinical applications [J]. World J Gastroenterol, 2010, 16(7): 832-836.
26	Kim AY, Han JK, Kim TK, et al. MR imaging of advanced gastric cancer: comparison of various MR pulse sequences using water and gadopentetate dimeglumine as oral contrast agents [J]. Abdom Imaging, 2000, 25(1): 7-13.
27	Anzidei M, Napoli A, Zaccagna F, et al. Diagnostic performance of 64-MDCT and 1.5-T MRI with high-resolution sequences in the T staging of gastric cancer: a comparative analysis with histopathology [J]. Radiol Med, 2009, 114(7): 1065-1079.
28	孟莉，鲍海华. 磁共振弥散加权成像与MSCT对胃癌患者术前分型及T分期诊断价值的比较 [J]. 世界华人消化杂志, 2015(15): 2435-2439.
29	Liu B, Ramalho M, AlObaidy M, et al. Gastrointestinal imaging-practical magnetic resonance imaging approach [J]. World J Radiol, 2014, 6(8): 544-566.
30	Gong J, Kang W, Zhu J, et al. CT and MR imaging of gastrointestinal stromal tumor of stomach: a pictorial review [J]. Quant Imaging Med Surg, 2012, 2(4): 274-279.
31	刘松，何健，管文贤, 等. 3.0T MR弥散加权成像在贲门癌T分期中的应用 [J]. 实用放射学杂志, 2013, 29(7): 1091-1093, 1097.
32	林家威，徐胜，黄顺荣, 等. 64排螺旋CT三期增强扫描判断胃癌淋巴结转移的临床价值 [J]. 中国肿瘤临床, 2011, 38(24): 1584-1587.
33	Morgan JW, Ji L, Friedman G, et al. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery [J]. JAMA Surg, 2015, 150(1): 37-43.
34	Liu X, Long Z, Cai H, et al. Analysis of lymph node metastasis correlation with prognosis in patients with T2 gastric cancer [J]. PLoS One, 2014, 9(8): e105112.
35	Monig SP, Zirbes TK, Schroder W, et al. Staging of gastric cancer: correlation of lymph node size and metastatic infiltration [J]. AJR Am J Roentgenol, 1999, 173(2): 365-367.
36	周竹萍，何健，刘松, 等. 磁共振弥散加权成像对胃癌淋巴结转移的诊断价值 [J]. 中华胃肠外科杂志, 2014, 17(3): 225-229.
37	Littooij AS, Kwee TC, Barber I, et al. Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard [J]. Eur Radiol, 2014, 24(5): 1153-1165.
38	Lawrence EM, Gallagher FA, Barrett T, et al. Preoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate- or high-risk prostate cancer [J]. AJR Am J Roentgenol, 2014, 203(3): W280-W286.
39	Park SO, Kim JK, Kim KA, et al. Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer [J]. J Magn Reson Imaging, 2009, 29(2): 383-390.
40	Lin G, Ho KC, Wang JJ, et al. Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T [J]. J Magn Reson Imaging, 2008, 28(1): 128-135.
41	张恭良，刘佳宾. 磁共振弥散加权成像在胃癌淋巴结转移中的分级与诊断意义研究 [J]. 世界复合医学, 2017, 3(3): 30-32, 95.
42	李丹燕，何健，朱斌, 等. 肝脏原发及转移性恶性肿瘤不同b值DWI的ADC值特点及变化趋势 [J]. 实用放射学杂志, 2013, 29(12): 1948-1952, 1962.
43	薛卫成，樊祥山，孟刚. 胃癌相关标志物免疫组化指标选择专家共识(2014) [J]. 临床与实验病理学杂志, 2014, (9): 951-953.
44	屈昭慧，高雪梅，程敬亮, 等. 扩散加权成像评价胃癌血管内皮生长因子表达及病理分化程度的研究 [J]. 中国医学影像学杂志, 2016, 24(9): 666-668, 673.
45	He J, Shi H, Zhou Z, et al. Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study [J]. BMC Cancer, 2015, 15: 749.
46	郑国淀，程向东，汪丽菁, 等. 胃腺癌磁共振扩散加权成像表观弥散系数与分子标记物Ki-67的相关性分析 [J]. 中华胃肠外科杂志, 2017, 20(7): 803-808.
47	郑欢欢，刘松，季长风, 等. 胃癌扩散加权成像ADC值与EGFR、Ki-67表达的相关性 [J]. 放射学实践, 2017, 32(9): 923-926.
48	胡友强. 体素内不相干运动弥散加权成像及动态对比增强MRI在胃癌诊断中的应用研究 [D]. 南充: 川北医学院, 2017.
49	Ji C, Zhang Q, Guan W, et al. Role of intravoxel incoherent motion MR imaging in preoperative assessing HER2 status of gastric cancers [J]. Oncotarget, 2017, 8(30): 49293-49302.
50	汪劭婷，朱朝晖，李小毅. 胃癌新辅助化疗疗效临床评价方法及进展 [J]. 中国普外基础与临床杂志, 2010, 17(2): 200-204.
51	Xu H, Wang W, Zhang X, et al. Application of regional arterial infusion chemotherapy in advanced gastric cancer [J]. J Cancer Therapy, 2018, 09(02): 118-129.
52	Sendler A. Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction [J]. Recent Results Cancer Res, 2010, 182: 167-177.
53	De Cobelli F, Giganti F, Orsenigo E, et al. Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology [J]. Eur Radiol, 2013, 23(8): 2165-2174.
54	唐磊，孙应实，李子禹, 等. 磁共振扩散加权成像表观扩散系数值与局部进展期胃癌新辅助化疗预后的关系 [J]. 中华胃肠外科杂志, 2015, 18(3): 221-226.
55	郭鹏，王屹，叶颖江, 等. 表观弥散系数在肝脏转移癌化学治疗疗效评价中的意义 [J]. 中国普外基础与临床杂志, 2011(05): 475-478.
56	Cheng J, Wang Y, Zhang C, et al. Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology [J]. World J Gastroenterol, 2017, 23(11): 1990.
57	Song X, Kang H K, Jeong G W, et al. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer [J]. World J Gastroenterol, 2016, 22(24): 5520.
58	曹智辉，郝长胜，王秀荣, 等. MRIDWI在胃癌诊断中的作用 [J]. 广东医学院学报, 2009, 27(5): 527-529.

[1]	Zaibo Zhang, Bingyu Wang, Zhikai Jiao, Bibo Tan. Risk factors for lower extremity deep venous thrombosis after gastric cancer surgery: A Meta-analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 475-480.
[2]	Tiantian Wang, Yuan Wen, Zhen Li, Meihong Ye, Ying Guo, Shuang Ma. The effect of honokiol on the sensitivity of gastric cancer cells to cisplatin chemotherapy by regulating the Nrf2/ARE pathway [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 202-209.
[3]	Xianyong Liu. Molecular mechanisms of gastric Lgr5⁺ stem cells, Mist1⁺ stem cells and Cck2r⁺ stem cells in carcinogenesis [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(03): 183-188.
[4]	Xin Wang, Danqi Sun, Jinyu Huang. Correlation of ADC histogram parameters from high-resolution diffusion-weighted imaging with clinical characteristics in rectal cancer: a retrospective study [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(02): 132-138.
[5]	Xiaojuan Han, Jiaqian Xu, Yulan Zhu, Ying Wang, Yuan Li, Jun Feng, Dong Shao. Construction and cell function study of HHLA2-overexpressing gastric cancer cells [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 373-377.
[6]	Guangjun Zhong, Chunhua Liu, Wansen Zhu, Xiaolei Xu, Zhaojun Wang. Application of conventional MRI combined with different scanning sequences in preoperative staging diagnosis, chemotherapy efficacy and prognosis evaluation of gastric cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 378-382.
[7]	Xiuyan Sun, Qinglei Xu, Pengtao Ma, Zhiyuan Hu, Chuanzhen Guo, Chenghong Zhu. Correlation analysis of body temperature changes during laparoscopic radical gastrectomy with pressure injury and microenvironment of the compression site [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 480-484.
[8]	Jing Sheng, Yong Mei, Pei Xia, Xiaolin Wang. Clinical study of second-line treatment of advanced gastric cancer with ubenimex combined with irinotecan [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(05): 317-321.
[9]	Hongyu Xu, Yashuang He. Efficacy of oxycodone and hydromorphone in postoperative analgesia after radical gastrectomy for gastric cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(05): 312-316.
[10]	Liu Yang, Lanqun Qin, Qian Geng, Dongqing Li, Chunjian Qi, Hua Jiang. Predictive value of efficacy and prognosis of soluble immune checkpoints for immunotherapy in patients with gastric cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(05): 305-311.
[11]	Huifeng Zhang, Peng Zhang, Xiaowei Zhu, Hong Yu. Research progress on exosomal long non-coding RNAs in gastric cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(01): 46-49.
[12]	Qing Dong, Fei Ding, Hao Guo, Feng Li. Expression and clinical significance of expression of Nesfatin-1/NUCB2 in early gastric cancer associated with Helicobacter pylori infection [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 783-789.
[13]	Lanfang Su, Hanjian Li, Jianghua Wang, Xudong Liu. Clinical value of ADC measurements in different diffusion-weighted imaging regions of interest in evaluating curative effect for rectal cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(02): 182-188.
[14]	Li Wang, Fan Fan, Guodong Chen, Yulan Liu, Liming Zhang. Short- and long-term outcomes of endoscopic submucosal dissection for early gastric cancer and characteristics of early cardiac gastric cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(02): 105-111.
[15]	Jiafeng Wang, Rui Guo, Qianqian Chen, Huikai Li, Bo Ning, Xinpu Yuan, Hua Zhu, Enqiang Linghu. A preliminary exploratory study of the impact of ⁶⁸Ga-NC-BCH combined with PET-CT lymph node immune tracer techniques on preoperative and postoperative clinical decision-making for gastric cancer patients [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2023, 10(04): 253-257.

Please choose a citation manager

Content to export